2011
DOI: 10.1074/mcp.m111.008540
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative Phospho-proteomics to Investigate the Polo-like Kinase 1-Dependent Phospho-proteome

Abstract: Polo-like kinase 1 (PLK1) is a key regulator of mitotic progression and cell division, and small molecule inhibitors of PLK1 are undergoing clinical trials to evaluate their utility in cancer therapy. Despite this importance, current knowledge about the identity of PLK1 substrates is limited. Here we present the results of a proteome-wide analysis of PLK1-regulated phosphorylation sites in mitotic human cells. We compared phosphorylation sites in HeLa cells that were or were not treated with the PLK1-inhibitor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
69
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(76 citation statements)
references
References 48 publications
5
69
1
Order By: Relevance
“…CDK1/cyclin B has a large number of mitotic substrates, including lamins, various lamina-associated proteins, and subunits of the NPC (for review see Guttinger et al 2009). Other relevant kinases are polo-like kinase 1 (PLK-1), which has multiple targets in mitosis, including subunits of the NPC (Grosstessner-Hain et al 2011;Laurell et al 2011); VRK1 (VRK-1), which phosphorylated BAF (Nichols et al 2006;Gorjanacz et al 2007); and the AIR-1 aurora kinase (Portier et al 2007). Counteracting the activity of these kinases are a number of phosphatases, including protein phosphatase 1 (PP1) and PP2A (Wurzenberger and Gerlich 2011).…”
Section: The Dynamic Nature Of the Nucleusmentioning
confidence: 99%
“…CDK1/cyclin B has a large number of mitotic substrates, including lamins, various lamina-associated proteins, and subunits of the NPC (for review see Guttinger et al 2009). Other relevant kinases are polo-like kinase 1 (PLK-1), which has multiple targets in mitosis, including subunits of the NPC (Grosstessner-Hain et al 2011;Laurell et al 2011); VRK1 (VRK-1), which phosphorylated BAF (Nichols et al 2006;Gorjanacz et al 2007); and the AIR-1 aurora kinase (Portier et al 2007). Counteracting the activity of these kinases are a number of phosphatases, including protein phosphatase 1 (PP1) and PP2A (Wurzenberger and Gerlich 2011).…”
Section: The Dynamic Nature Of the Nucleusmentioning
confidence: 99%
“…Given the inherent complexity of cellular proteome, prefractionation is prerequisite to improve the coverage of cellular phosphoproteome. For example, the combination of SCX and IMAC or MOAC has been proven to be an excellent strategy for phosphoproteome analysis 12,[44][45][46][47][48][49][50][51] .…”
Section: Introductionmentioning
confidence: 99%
“…A number of studies have taken a proteomics approach to identify mitotic PLK1 PBD-dependent binding partners and substrates [20,21]. However, these studies have identified few novel regulators of G2/M phase progression.…”
Section: Accepted M Manuscriptmentioning
confidence: 99%
“…We have identified a number of proteins previously identified as PLK1 binding proteins, including JIP4, as well as a number of novel interactors. The Polobox binding site identified in JIP4 was phospho-Thr217, but a phosphoproteomics screen for PLK1 phosphorylation sites found this site was not responsive to the PLK1 inhibitor BI-4834 [21]. Two other sites were identified as PLK1 phosphorylation sites on JIP4, Ser183/185 and Ser 311 [23], although neither of these match consensus Polobox binding sites [20].…”
mentioning
confidence: 99%